Sunday, Oct 25, 2026
Focus on the big picture

Novavax vaccine over 90% effective in U.S. trial

Reuters, 14 Jun 2021
Novavax reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus

#News #Reuters #Vaccine #Novavax #VaccineTrial #Covid #Coronavirus

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles